Kynam Capital Management, LP Syndax Pharmaceuticals Inc Transaction History
Kynam Capital Management, LP
- $1.22 Billion
- Q3 2024
A detailed history of Kynam Capital Management, LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Kynam Capital Management, LP holds 5,842,925 shares of SNDX stock, worth $97.6 Million. This represents 9.23% of its overall portfolio holdings.
Number of Shares
5,842,925
Previous 5,722,057
2.11%
Holding current value
$97.6 Million
Previous $117 Million
4.25%
% of portfolio
9.23%
Previous 9.15%
Shares
11 transactions
Others Institutions Holding SNDX
# of Institutions
228Shares Held
88.4MCall Options Held
1.01MPut Options Held
692K-
Black Rock Inc. New York, NY7.91MShares$132 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA4.99MShares$83.3 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$81.6 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.11MShares$68.6 Million6.25% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.89MShares$64.9 Million1.13% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $945M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...